This is a partial transcript from Your World with Neil Cavuto, November 21, 2003, that was edited for clarity.
Watch Your World w/Cavuto weekdays at 4 p.m. and 1 a.m. ET.
NEIL CAVUTO, HOST: Well, you know first there was Viagra (search). Then came Levitra (search). And now, to make the hat trick, Cialis (search), the latest male impotence drug that some say could prove even bigger than the big names that preceded it.
With us now, the head of the company that makes Cialis, Eli Lilly's Sidney Taurel (search).
Mr. Taurel, welcome. Good to have you.
SIDNEY TAUREL, ELI LILLY CHAIRMAN AND CEO: Thank you. Good to be here.
CAVUTO: Is it getting too crowded?
TAUREL: I don't think so. Our experience in launching Cialis in 50 countries around the world has shown that there is a lot of room for a new drug, which, one, expands the market, and two, takes some market share away from the existing competitors. We have reached market shares of 20 to 30 percent in most countries, and some even further, 40 percent price in Australia.
CAVUTO: All right. Now, the big draw, I hear, with this, is the fact that it lasts for 36 hours.
CAVUTO: What is lasting for 36 hours?
TAUREL: The possibility to have an erection when you want to have one. In other words, you won't have it for that period of time. So what this means is that couples really can have a much more natural life and not have to plan their intimacy around taking the pill. They can take it and forget about it for 36 hours, and when the moment is right they'll be ready.
CAVUTO: All right. Now, that is a big draw here, the 36-hour figure. Now, that would be, what, nine times longer than Viagra, right.
CAVUTO: All right. So can you stick by that research that that is true?
TAUREL: Very much so, and so does the FDA. It's part of our label.
CAVUTO: Okay, because if that is the case, I mean, life is going to stop for a lot of people for those 36 hours. But that is what you are banking on, right? I mean, that clearly has got to be your draw. This time factor is one that you argue is decidedly in your advantage over Viagra or Levitra, correct?
TAUREL: Very much so. What we hear from a lot of couples is that they feel that there is the man, the woman and the pill in the bed. And that, you know, they have to plan their intimacy around taking a drug. And with Cialis, they don't have to do that.
CAVUTO: All right. I wonder what this will do with this talk of Medicare prescription drug coverage, whether a drug like this would fall under that. What do you know about that?
TAUREL: That reimbursement is fairly limited for drugs like this.
TAUREL: But in general, I think this drug benefit will be a very good thing for America and for America's seniors. It is not a perfect bill, but one that we welcome.
CAVUTO: What would be the average age of your user?
TAUREL: Oh, its hard to tell, but we know that about 50 percent of men above the age of 40 have some form of sexual impotence.
CAVUTO: All right. So -- but there is a good possibility that many young men could use this as well?
TAUREL: Well, we are not going to promote it to young men. We are going to promote it to people who have sexual dysfunction. And you will see that in our ads, and the ads will be very much geared at the couple, rather than the man, and at romance rather than performance.
CAVUTO: All right. Sidney Taurel, thank you very much. Eli Lilly is the company, he runs it. The drug is Cialis. Again, in the male impotence arena, the latest entry. Thank you, sir. Appreciate it.
TAUREL: You're welcome.
Content and Programming Copyright 2003 Fox News Network, Inc. ALL RIGHTS RESERVED. Transcription Copyright 2003 eMediaMillWorks, Inc. (f/k/a Federal Document Clearing House, Inc.), which takes sole responsibility for the accuracy of the transcription. ALL RIGHTS RESERVED. No license is granted to the user of this material except for the user's personal or internal use and, in such case, only one copy may be printed, nor shall user use any material for commercial purposes or in any fashion that may infringe upon Fox News Network, Inc.'s and eMediaMillWorks, Inc.'s copyrights or other proprietary rights or interests in the material. This is not a legal transcript for purposes of litigation.